Patent details

Basic Information

Publication number:

EP3430045

PCT Application Number:

EP2017056246

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177127255

PCT Publication Number:

WO2017158097

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-TNFALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF

French Title of Invention:

ANTICORPS ANTI-TNF ALPHA ET FRAGMENTS FONCTIONNELS DE CEUX-CI

German Title of Invention:

ANTI-TNF-ALPHA-ANTIKÖRPER UND FUNKTIONALE FRAGMENTE DAVON

SPC Number:

Dates

Filing date:

16/03/2017

Grant date:

23/08/2023

EP Publication Date:

23/01/2019

PCT Publication Date:

21/09/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/08/2023

EP B1 Publication Date:

23/08/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/03/2024

Expiration date:

16/03/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/08/2023

 

 

Name:

Tillotts Pharma AG

Address:

Baslerstrasse 15, 4310 Rheinfelden, Switzerland (CH)

Inventor

1

Name:

MEYER, Sebastian

Address:

Switzerland (CH)

2

Name:

FURRER, Esther Maria

Address:

Switzerland (CH)

3

Name:

GUNDE, Tea

Address:

Switzerland (CH)

Priority

Priority Number:

16160918

Priority Date:

17/03/2016

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07K 16/24; A61P 1/00;

Publication

European Patent Bulletin

Issue number:

202334

Publication date:

23/08/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages